These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17666315)

  • 1. Efficacy of the combination of fluticasone propionate and salmeterol in patients with moderate persistent asthma within a "real-life" setting.
    Trautmann M; Banik N; Tews JT; Jörres RA; Nowak D
    Eur J Med Res; 2007 Jun; 12(6):255-63. PubMed ID: 17666315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
    Schermer TR; Albers JM; Verblackt HW; Costongs RJ; Westers P
    Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma.
    Nelson HS
    J Allergy Clin Immunol; 2001 Feb; 107(2):398-416. PubMed ID: 11174215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
    Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
    Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients.
    Adachi M; Aizawa H; Ishihara K; Ohta K; Sano Y; Taniguchi H; Nakashima M
    Respir Med; 2008 Jul; 102(7):1055-64. PubMed ID: 18394875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
    J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial.
    Ulrik CS; Claudius BK; Tamm M; Harving H; Siersted HC; Backer V; Hellquist B; Dahl R; Høgholm A; Jøhnk IK
    Clin Respir J; 2009 Jul; 3(3):161-8. PubMed ID: 20298399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE; Hagiwara M; Stanford RH; Stempel DA
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
    O'Connor RD; Gilmore AS; Manjunath R; Stanford RH; Legorreta AP; Jhingran PM
    Curr Med Res Opin; 2006 Mar; 22(3):453-61. PubMed ID: 16574029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.
    Lundbäck B; Rönmark E; Lindberg A; Jonsson AC; Larsson LG; Pétavy F; James M
    Respir Med; 2006 Jan; 100(1):2-10. PubMed ID: 16243498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients].
    Miyagawa T
    Arerugi; 2008 Nov; 57(11):1134-44. PubMed ID: 19052508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
    Koopmans JG; Lutter R; Jansen HM; van der Zee JS
    J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study.
    Pedersen SE; Bateman ED; Bousquet J; Busse WW; Yoxall S; Clark TJ;
    J Allergy Clin Immunol; 2007 Nov; 120(5):1036-42. PubMed ID: 17935765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Asthma control with the salmeterol-fluticasone-combination disc compared to standard treatment].
    Molitor S; Liefring E; Trautmann M
    Pneumologie; 2005 Mar; 59(3):167-73. PubMed ID: 15756629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
    Stempel DA; Riedel AA; Carranza Rosenzweig JR
    Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma.
    Li HT; Zhang TT; Zhou H; Qu XJ; Wu WM; Huang J
    Respiration; 2007; 74(1):33-43. PubMed ID: 17008769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.